E
Cytosorbents Corporation CTSO
$1.10 -$0.03-2.66%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income 43.66% 34.84% -8.96% 36.53% -49.41%
Total Depreciation and Amortization -3.96% 0.74% -44.09% 71.36% 1.14%
Total Amortization of Deferred Charges 1,879.44% -200.00% -- -- --
Total Other Non-Cash Items -220.46% -31.31% 269.75% -142.88% 81,775.61%
Change in Net Operating Assets 146.12% -101.97% -1,943.07% -55.69% 113.62%
Cash from Operations 48.67% 0.73% 24.62% -23.07% 24.91%
Capital Expenditure -733.52% 59.73% 52.67% 32.94% -168.00%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities -44.29% -24.21% -102.48% 64.96% -66.62%
Cash from Investing -148.87% 5.59% 6.55% 47.26% -283.68%
Total Debt Issued -100.00% -- -- -- --
Total Debt Repaid 100.00% -600.00% -- -- --
Issuance of Common Stock -- -100.00% -99.56% 1,783.46% -30.37%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities 92.71% -- -- -- --
Cash from Financing -101.01% 1,819.94% -104.68% 1,783.46% -30.37%
Foreign Exchange rate Adjustments 222.06% -1,303.45% 105.88% -526.84% 166.00%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -157.18% 187.82% -199.18% 216.19% 18.73%
Weiss Ratings